ARGUS reiterates a 'Buy' on CBL & Associates (NYSE: CBL), but lowers price target from $15 to $12.

This article: 136 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE